Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04887662 · ClinicalTrials.gov registry record · NA

Happy Gut Study - Fermented Vegetables and Cardiovascular Biomarkers

A NA study, sponsored by University of North Florida.

Completed
Registry status
NA
Development phase
87
Enrollment target

NCT04887662: Completed NA study, sponsored by University of North Florida.

NCT04887662 is a NA study that has completed, run by University of North Florida. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04887662, a NA study, has completed, sponsored by University of North Florida.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target

Study Summary

The purpose of this project is to determine whether regular consumption of fermented vegetables can decrease inflammation and change the types of bacteria that are normally present in the large intestine. Recent research studies have linked the gut bacteria to many disorders and conditions, such as obesity, cardiovascular disease, diabetes, etc. We also know that certain bacteria are considered probiotic bacteria because they contribute to a healthy gut, while others have been associated with inflammation and disease. Fermented foods may contain beneficial bacteria that may improve health in humans. However, there is a lack of research studies examining the effects of regular consumption of fermented foods on health. This study will help investigators better understand if regular consumption of fermented vegetables can improve inflammation and change the gut bacteria towards a more beneficial profile.

Primary Outcome

ng/mL

Interventions

  • OTHER Fermented vegetable

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2021-05-05
Est. Completion 2021-12-06
Phase NA
University of North Florida

4 total trials

What the finished NCT04887662 record still lists

NCT04887662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Fermented vegetable is the first listed.

NCT04887662 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04887662 about?

NCT04887662 is a clinical study titled "Happy Gut Study - Fermented Vegetables and Cardiovascular Biomarkers". The purpose of this project is to determine whether regular consumption of fermented vegetables can decrease inflammation and change the types of bacteria that are normally present in the large intestine. Recent research studies have linked the gut bacteria to many disorders and conditions, such as ...

What is the current status of trial NCT04887662?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2021-05-05. Estimated completion is 2021-12-06.

What interventions are being tested in trial NCT04887662?

The interventions under investigation include: Fermented vegetable (OTHER).

Who is sponsoring clinical trial NCT04887662?

This trial is sponsored by University of North Florida, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04887662's enrollment target sits among peer trials

87 974th of 2000 higher than 1,025 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03292601 · 87 participants · NA

    Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)

  • NCT04291105 · 87 participants · Phase 2

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  • NCT04565795 · 87 participants · NA

    Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

  • NCT05607004 · 87 participants · Phase 2

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04887662, the US trial registry maintained by the National Library of Medicine. NCT04887662 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.